Mounjaro and Wegovy for PCOS: The Direct Answer
Mounjaro and Wegovy are not licensed as treatments for PCOS itself; both are licensed for weight management, but a doctor may consider them for a patient with PCOS and excess weight when weight is the main obstacle [1, 2]. Current evidence supports their value for weight loss and metabolic health far more than any direct effect on ovulation or pregnancy, and research on Mounjaro specifically (tirzepatide) in PCOS is still at an early stage [7, 8].
The right decision starts with an assessment: is the PCOS confirmed, is there insulin resistance, is a pregnancy planned soon, and which medicines are already being taken. At La Rose Clinics, Dr Shimaa Fouad, a physician and clinical nutrition and weight-management specialist and ESPEN member, follows Mounjaro and Wegovy patients in New Maadi and Fifth Settlement, and you can reserve through Book your appointment.
This article answers the practical questions in detail: how PCOS relates to weight and insulin resistance, what the research and international guideline actually say, whether periods become regular, how to avoid an unplanned pregnancy, how the injections compare with metformin and lifestyle, and when they are appropriate at all.
PCOS, Insulin Resistance and Weight: How They Connect
PCOS is a hormonal disorder that affects the ovaries and many other parts of the body. It is usually diagnosed when two of three features are present: irregular or absent ovulation or periods, signs of high androgens (extra hair and acne), and a polycystic appearance of the ovaries on ultrasound [6, 9]. The 2023 international guideline puts its prevalence at 10 to 13% worldwide [1]. Difficulty losing weight and dark, thickened patches of skin are also common [9].
Insulin resistance is thought to play a part. The body responds less well to insulin, so blood glucose can rise, and the extra insulin may push the ovaries to make more androgens [6, 9]. The international guideline treats insulin resistance as a pathophysiological factor in PCOS [1], while also saying that insulin assays available in clinics should not be used in routine care [1]. In practice, then, assessment rests on symptoms, examination and HbA1c or fasting glucose rather than a stand-alone insulin number. If you have a darkened neck, read about it in dark neck and insulin resistance.
Weight enters the picture in both directions. Cleveland Clinic states that 40% to 80% of people with PCOS have obesity, and that healthy weight management can improve insulin levels and cycle regularity [6]. MedlinePlus says PCOS is linked with weight gain but does not state which causes the other [9]. A useful way to see it is that each feeds the other: more weight raises insulin resistance, and insulin resistance makes losing weight harder.
That is why any treatment plan starts from the same place: confirm the diagnosis, run the right tests, build a lifestyle plan you can sustain, and only then ask whether a medicine is needed. More on this link is in PCOS and weight: what happens and what helps.
What the Research and the International Guideline Actually Say
Start with the 2023 evidence-based international guideline. It says anti-obesity medicines, naming liraglutide and semaglutide, can be an option alongside active lifestyle intervention for adults with PCOS and a higher weight [1]. It requires effective contraception whenever pregnancy is possible, because pregnancy safety data are lacking [1]. And it asks clinicians to discuss the high risk of weight regain after stopping and the lack of long-term safety data [1]. Note that the text we read names liraglutide and semaglutide but not tirzepatide, so the guideline's recommendation is not built on Mounjaro specifically.
What about the trials? A 2023 meta-analysis in BMC Endocrine Disorders covered 11 randomised trials and 840 women with PCOS taking GLP-1 type medicines. It found lower BMI (about 1.21 BMI points) and waist circumference (about 2.90 cm), a better natural pregnancy rate (relative risk 1.72), better menstrual regularity and a slight fall in testosterone [7]. But the authors themselves flagged marked differences between studies (I2 reached 95.6% for menstrual regularity), that some participants also took metformin, that most were living with obesity, that most trials were not designed to measure menstrual patterns, and that larger, longer trials are needed [7].
A more recent review (a 2025 conference abstract in the Journal of the Endocrine Society) pooled 10 trials and 730 participants. It found significant falls in BMI and total testosterone, but huge heterogeneity (I2 between 99 and 100%), no pooled estimate for menstrual regularity, and a call for further studies on ovulation and fertility [8].
The honest summary: the overall direction is positive, but the certainty is low to moderate, and most of it comes from medicines older than Mounjaro. Because Mounjaro produces larger weight loss in general use, it is reasonable to expect any benefit in PCOS to come largely through weight, but that is an inference rather than the result of a completed trial. We could not open a completed large randomised trial of tirzepatide in PCOS, and we will update if results appear. For a side-by-side look at the medicines, read the GLP-1 medication guide.
Periods and Ovulation: Do They Become Regular?
Many patients ask: does Mounjaro regulate periods? The honest answer is that it may, as weight comes down, but there is no promise. The pooled analysis of GLP-1 type medicines recorded better menstrual regularity, with large differences between studies, and the most recent review gave no pooled figure for periods and asked for studies dedicated to ovulation and fertility [7, 8]. So improvement is plausible, but improvement in every patient, or at the same speed, is not established.
Why might periods improve? Healthy weight management can improve insulin levels and cycle regularity in PCOS [6], and better insulin sensitivity reduces the drive to make androgens, which gives the ovary a chance to ovulate more regularly. In other words, the cycle improves when the metabolic picture improves, rather than because the medicine acts on the ovary directly, as far as we know.
Two cautions apply. First, rapid weight loss or very low food intake can itself delay periods, so tracking the cycle is part of follow-up, and a delay after starting treatment should not automatically be blamed on PCOS. If a period is late and pregnancy is possible, take a pregnancy test before anything else. Second, trial results describe averages, and an average hides differences between one patient and another.
What are the alternatives for regulating periods? The NHS lists the combined pill, the progestogen-only pill or an intrauterine system for irregular periods [5], and Cleveland Clinic notes that hormonal birth control helps regulate the cycle and can improve acne and hair growth [6]. These treat the cycle itself, suit those who are not trying to conceive, and can run alongside a weight plan if the doctor considers it right.
Signs that call for early assessment: cycles longer than 40 days, signs of excess androgens, or difficulty conceiving [6]. Periods that disappear for months on treatment or after rapid weight loss need examination, not waiting.
Contraception and Pregnancy Planning: The Part That Cannot Wait
This is the most important section in the article. PCOS can make conception harder for some women, but it does not prevent it, and MedlinePlus notes that many women with PCOS can become pregnant [9]. With weight loss and better cycles, ovulation may return, so the chance of an unplanned pregnancy can actually rise. That is why the international guideline calls for effective contraception whenever pregnancy is possible [1].
The product labels are specific. The European Mounjaro information advises women of childbearing potential to use contraception, does not recommend it during pregnancy or in those trying to conceive, and asks for it to be stopped at least one month before a planned pregnancy because of its long half-life [3]. The US Wegovy label says women of reproductive potential should stop it at least two months before a planned pregnancy [4]. The US Zepbound label says to discontinue it when pregnancy is recognised [2].
Then there is the contraceptive pill. The medicine slows stomach emptying and can affect how well oral medicines are absorbed [2]. The US label advises adding a barrier method for 4 weeks after starting and after each dose increase [2], while the European text reports that a single dose reduced pill exposure by an amount not considered clinically relevant, with no adjustment required [3]. The wording differs between the two regulators, so the cautious course is to discuss it with the doctor: an extra method at the start and after each increase, or a non-oral method such as an intrauterine device.
If pregnancy is part of your plan, the practical order is:
1. Before starting, tell the doctor that pregnancy is possible within the next year. 2. Set an approximate date, and count back the stopping period required before it. 3. Discuss a plan to hold your weight after stopping, because regain is a real possibility [1]. 4. If pregnancy happens during treatment, stop the medicine and speak to the doctor straight away [2, 3].
A general reassurance is not enough here. If pregnancy is on your horizon, read more in GLP-1 injections, contraception and pregnancy and in weight-loss medicines before pregnancy. On breastfeeding, data are limited: the US label says there are no data [2] and the European text says use could be considered [3], so the decision is individual.
An Honest Comparison with Metformin and Lifestyle
The sensible order of options starts with lifestyle, not injections. The international guideline recommends lifestyle intervention for everyone with PCOS [1], and the NHS advises a healthy balanced diet, regular exercise and trying to lose weight if overweight, adding that weight-loss medicines may be considered [5]. So injections are a possible add-on, not a replacement for the foundation.
As for metformin, the guideline says it can be considered alone in adults with PCOS and a BMI of 25 or more for anthropometric and metabolic outcomes [1]. The NHS describes it as a type 2 diabetes medicine that helps with tiredness and weight problems [5], and Cleveland Clinic says it helps the body process insulin and that some people see better cycles [6]. MedlinePlus notes that insulin-sensitising medicines are not FDA approved for PCOS specifically [9]. So metformin is also used off-label in many cases, but it is older, with a longer record and broader data.
The side effects of metformin are mostly digestive: nausea, vomiting, diarrhoea, tummy pain, loss of appetite and altered taste, and vitamin B12 deficiency can occur and cause tiredness [10]. It is not suitable for people with significant liver or kidney problems, heart failure and some others [10]. The B12 details are in metformin and vitamin B12.
A simple decision guide:
1. Normal weight and irregular periods: lifestyle, plus a cycle treatment (a pill or similar) depending on whether pregnancy is wanted. 2. Mild excess weight with PCOS: structured lifestyle first, and metformin may be considered. 3. Obesity or excess weight with complications (diabetes, blood pressure, sleep problems) and lifestyle alone has not been enough: GLP-1 medicines are discussed with the doctor. 4. Pregnancy planned within months: pregnancy planning comes before starting any injection.
Options can also be combined, and the pooled trials themselves included participants who were also on metformin [7], which complicates a direct comparison of injections against metformin. Nobody can say precisely that a particular injection beats metformin in PCOS, because no completed head-to-head comparison settles that for Mounjaro.
Who Is a Candidate, Side Effects and Follow-Up
These injections are usually discussed when several things come together: a confirmed diagnosis of PCOS, clear excess weight or obesity, structured lifestyle efforts that were not enough, no pregnancy planned soon, and no contraindications. Situations that need to be postponed or looked at carefully include pregnancy or planning one, breastfeeding, a history of pancreatitis, gallbladder disease, severe delayed stomach emptying, and a personal or family history of medullary thyroid cancer [2]. The Zepbound label carries a boxed warning about thyroid C-cell tumours in rats, and this rules out use in anyone with that history [2].
The most common side effects listed on the label are nausea, diarrhoea, vomiting, constipation, abdominal pain and indigestion [2]. They are usually mild to moderate and worse at the beginning, and there are practical ways to reduce them such as smaller, lower-fat meals and enough fluids. Watch hydration too, because persistent vomiting and diarrhoea put a strain on the kidneys.
Red flags that need urgent assessment:
1. Severe, persistent pain in the upper abdomen that may reach the back, with or without vomiting, because it could be pancreatitis and the medicine should be stopped if it is suspected [2]. 2. Pain in the upper right abdomen with fever or yellowing, because it could be gallbladder inflammation [2]. 3. Vomiting or diarrhoea that will not stop, and being unable to drink. 4. A lump or swelling in the neck, persistent hoarseness or difficulty swallowing. 5. A late period when pregnancy is possible.
More detail is in warning signs and serious side effects.
Follow-up covers weight, waist and blood pressure, HbA1c where relevant, the cycle and any change in it, tolerance of food and digestive symptoms, adequate protein intake, and a review of the contraceptive method. After stopping, the guideline warns about the risk of weight regain [1], so we plan the stop from the start rather than being surprised by it. The article on PCOS and weight regain covers this, and the plan after Mounjaro is in stopping Mounjaro and a plan to prevent weight regain.
Follow-Up at La Rose Clinics: Maadi and Fifth Settlement
The Maadi branch is at 14 El-Mokhtar Street, off El-Nasr Street behind QNB Bank, in New Maadi. The Fifth Settlement branch is in CMC Medical Mall, 4th floor, North 90th Street, behind the Air Force Specialized Hospital. Dr Shimaa Fouad sees weight-management patients and follows Mounjaro and Wegovy treatment in Maadi on Saturday, Monday and Tuesday from 3 to 8 pm, and in Fifth Settlement on Wednesday from 3:30 to 8 pm. Dr Alyaa Said Abu Taleb, a clinical nutrition specialist, sees patients in Maadi only, on Saturday and Monday from 2 to 7 pm. Schedules can change and are confirmed when booking.
The first visit for a PCOS case usually covers: the history of periods and symptoms and any earlier or planned attempts at pregnancy, current medicines, measurement of weight, waist and blood pressure, a review of the tests you bring (glucose, HbA1c, lipids and hormones if available), then an eating and activity plan that fits your routine and work, and an honest decision on whether the injections are appropriate now. If pregnancy is close, it comes before any injection. International clinical guidelines for PCOS emphasize that comprehensive medical evaluation and lifestyle intervention form the essential first line before prescribing any weight-management pharmacotherapy [1].
You can read about the full programme in PCOS and weight loss in Maadi, and about follow-up by area in Mounjaro and Wegovy in Maadi and Mounjaro and Wegovy in Fifth Settlement.
To book, call or send a WhatsApp message to 010 4066 1893, or use Book your appointment. Any question about cost can be sent on WhatsApp.
Common Mistakes and Myths
Myth: Mounjaro is a treatment for PCOS. In fact it is licensed for weight management, and PCOS is not among the licensed uses in the labels we reviewed [2, 3]. Any improvement in periods most likely comes through weight and metabolism.
Myth: if periods become regular, pregnancy cannot happen. The opposite can be true: once ovulation returns, pregnancy is possible, so contraception does not stop [1].
Myth: metformin or the injections alone are enough. The international guideline combines any medicine with lifestyle intervention [1].
Mistake: starting the injections when a pregnancy is planned soon, or stopping suddenly without a plan to hold your weight [1, 3, 4].
Mistake: buying the injections without an assessment and blood tests. A proper work-up rules out other causes of irregular periods, such as thyroid problems, and confirms whether PCOS really explains them.
Mistake: judging by one month. Cycles and ovulation take time, and the pooled trials suggest longer treatment was associated with a better menstrual pattern [7].
